Funder
Marie-Curie Reintegration Grant
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,Oncology
Reference60 articles.
1. Orphanet. A portal for rare diseases and orphan drugs:
https://www.orpha.net/orphacom/cahiers/docs/DE/Verzeichnis_der_seltenen_Krankheiten_in_alphabetischer_Reihenfolge.pdf
. Accessed 08 2017.
2. American Association of Neurological Surgeons:
https://www.aans.org/en/Patients/Neurosurgical-Conditions-and-Treatments/Glioblastoma-Multiforme
. Accessed 08 2017.
3. Miranda A, Blanco-Prieto M, Sousa J, Pais A, Vitorino C. Breaching barriers in glioblastoma. Part I: molecular pathways and novel treatment approaches. Int J Pharm. 2017. pii: S0378–5173(17)30664–6. doi:
https://doi.org/10.1016/j.ijpharm.2017.07.056
. Review.
4. Mineo JF, Bordron A, Baroncini M, Ramirez C, Maurage CA, Blond S, Dam-Hieu P. Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients. ActaNeurochir (Wien). 2007;149(3):245–53.
5. Navarria P, Pessina F, Tomatis S, Soffietti R, Grimaldi M, Lopci E, Chiti A, Leonetti A, Casarotti A, Rossi M, Cozzi L, Ascolese AM, Simonelli M, Marcheselli S, Santoro A, Clerici E, Bello L, Scorsetti M. Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study. Oncotarget. 2017.doi:
https://doi.org/10.18632/oncotarget.18809
. PMID: 28700357.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献